ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 56 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $84,000 | -84.4% | 138,666 | -75.1% | 0.00% | – |
| Q3 2021 | $540,000 | +3076.5% | 557,157 | +3449.4% | 0.00% | – |
| Q2 2021 | $17,000 | -95.6% | 15,697 | -96.2% | 0.00% | – |
| Q1 2021 | $390,000 | +2337.5% | 414,540 | +1970.9% | 0.00% | – |
| Q3 2020 | $16,000 | -51.5% | 20,017 | -67.0% | 0.00% | – |
| Q2 2020 | $33,000 | +73.7% | 60,632 | +11.7% | 0.00% | – |
| Q1 2020 | $19,000 | 0.0% | 54,273 | +94.6% | 0.00% | – |
| Q3 2019 | $19,000 | -90.2% | 27,885 | -69.7% | 0.00% | – |
| Q1 2019 | $194,000 | +28.5% | 92,126 | +113.5% | 0.00% | – |
| Q1 2018 | $151,000 | -20.5% | 43,150 | +0.1% | 0.00% | – |
| Q4 2017 | $190,000 | +25.0% | 43,117 | +48.2% | 0.00% | – |
| Q3 2017 | $152,000 | +149.2% | 29,100 | +149.7% | 0.00% | – |
| Q2 2017 | $61,000 | -26.5% | 11,654 | -52.1% | 0.00% | – |
| Q3 2016 | $83,000 | – | 24,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
| Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
| Founders Capital Management | 8,000 | $6,000 | 0.01% |
| Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
| Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
| Firestone Capital Management | 5,200 | $4,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |